Give Back To The Future

The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.

While we will never be satisfied until the cure is found, we take pride in our clear, wide-ranging track record of impact on the Parkinson's research field:

- In our preclinical portfolio, MJFF-funded investigations have resulted in more than 20 early-stage therapeutic programs, which have attracted follow-on funding from venture capital, pharmaceutical or government funders for continuing development.

- In our clinical portfolio, we have funded or sponsored scores of clinical trials in partnership with both academic and industry teams. Today, more than 15 disease-modifying interventions are in clinical trials. Multiple improved symptomatic therapies have achieved regulatory approval or are poised to do so.

- The landmark MJFF-sponsored Parkinson's Progression Markers Initiative has built the most robust dataset and biosample library in the history of Parkinson’s research. Data from brain scans (e.g., MRI, DaTscan), biosample analysis (e.g., spinal fluid protein levels) and intensive “omics” investigations (e.g., whole genome and RNA sequencing) from 1,500 volunteers has been downloaded by researchers over 1.7 million times since the study's launch in 2010.